261 related articles for article (PubMed ID: 12180723)
1. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.
Maksymowych WP; Jhangri GS; Aspeslet L; Abel MD; Trepanier DJ; Naicker S; Freitag DG; Cooper BL; Foster RT; Yatscoff RW
J Rheumatol; 2002 Aug; 29(8):1646-52. PubMed ID: 12180723
[TBL] [Abstract][Full Text] [Related]
2. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
Moriuchi-Murakami E; Yamada H; Ishii O; Kikukawa T; Igarashi R
J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats].
Yao ZQ; Zhao JX; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3055-8. PubMed ID: 17288836
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
5. NK95806, a newly synthesized microtubule-disrupting agent that suppresses collagen-induced arthritis in mice.
Morohashi H; Abe F; Saiga K; Toyoda E; Ichimura E; Nishikawa K
Int Immunopharmacol; 2004 Nov; 4(12):1437-43. PubMed ID: 15351313
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis.
Kawabata D; Tanaka M; Fujii T; Umehara H; Fujita Y; Yoshifuji H; Mimori T; Ozaki S
Arthritis Rheum; 2004 Feb; 50(2):660-8. PubMed ID: 14872511
[TBL] [Abstract][Full Text] [Related]
9. Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes.
Cai Y; Chen T; Xu Q
Inflamm Res; 2003 Aug; 52(8):334-40. PubMed ID: 14504671
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
Hai le X; Kogure T; Niizawa A; Fujinaga H; Sakakibara I; Shimada Y; Watanabe H; Terasawa K
J Rheumatol; 2002 Aug; 29(8):1601-8. PubMed ID: 12180716
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats.
García-González A; Lotz M; Ochoa JL
Rev Invest Clin; 2009; 61(3):212-20. PubMed ID: 19736810
[TBL] [Abstract][Full Text] [Related]
12. Effects of Sandimmune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology.
Beckmann N; Bruttel K; Schuurman H; Mir A
J Magn Reson; 1998 Mar; 131(1):8-16. PubMed ID: 9533900
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
Verdrengh M; Isaksson O; Tarkowski A
Rheumatology (Oxford); 2005 Feb; 44(2):183-6. PubMed ID: 15494349
[TBL] [Abstract][Full Text] [Related]
14. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
15. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
16. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis.
Ostberg T; Wähämaa H; Palmblad K; Ito N; Stridh P; Shoshan M; Lotze MT; Harris HE; Andersson U
Arthritis Res Ther; 2008; 10(1):R1. PubMed ID: 18179697
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
[TBL] [Abstract][Full Text] [Related]
19. Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis.
Boyle DL; Kim HR; Topolewski K; Bartok B; Firestein GS
J Pharmacol Exp Ther; 2014 Feb; 348(2):271-80. PubMed ID: 24244039
[TBL] [Abstract][Full Text] [Related]
20. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
